- Conditions
- Male Reproductive Problem
- Interventions
- Cannabis plant (THC 20mg), Cannabis (0%/ THC / 0% CBD), Cannabis plant (THC 40mg)
- Drug
- Lead sponsor
- Kanako Hayashi
- Other
- Eligibility
- 21 Years to 64 Years · Male only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Pullman, Washington
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Men Carrying 2 Minor Alleles for Choline Dehydrogenase rs12676, Male Infertility
- Interventions
- Betaine supplement
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 18 Years to 60 Years · Male only
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014 – 2016
- U.S. locations
- 1
- States / cities
- Kannapolis, North Carolina
- Conditions
- Erectile Dysfunction
- Interventions
- Levitra (Vardenafil, BAY38-9456), Sildenafil, Placebo
- Drug
- Lead sponsor
- Bayer
- Industry
- Eligibility
- 25 Years to 64 Years · Male only
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2006
- U.S. locations
- 18
- States / cities
- Phoenix, Arizona • Tempe, Arizona • Beverly Hills, California + 15 more
- Conditions
- Male Contraception, Semen Volume, Sperm Motility
- Interventions
- NLS-133, Placebo, Active Comparator #1
- Drug
- Lead sponsor
- Next Life Sciences
- Industry
- Eligibility
- 18 Years to 55 Years · Male only
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Oligospermia, Teratospermia, Asthenozoospermia, Male Infertility
- Interventions
- Ramipril, Placebo
- Drug
- Lead sponsor
- Weill Medical College of Cornell University
- Other
- Eligibility
- 18 Years to 45 Years · Male only
- Enrollment
- 2 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2013 – 2016
- U.S. locations
- 1
- States / cities
- New York, New York
- Conditions
- Infertility, Male Infertility, InVitro Fertilization, Aneuploidy Rate, Euploidy Rate
- Interventions
- microfludics semen processing device
- Device
- Lead sponsor
- MotilityCount aps
- Industry
- Eligibility
- 21 Years to 45 Years
- Enrollment
- 1,600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 1
- States / cities
- Farmington, Connecticut
- Conditions
- Safety Issues
- Interventions
- Celastrol
- Dietary Supplement
- Lead sponsor
- Legend Labz, Inc.
- Industry
- Eligibility
- 18 Years to 40 Years · Male only
- Enrollment
- 5 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Baton Rouge, Louisiana
- Conditions
- Secondary Hypogonadism
- Interventions
- 25 mg Androxal, Testim 1%
- Drug
- Lead sponsor
- Repros Therapeutics Inc.
- Industry
- Eligibility
- 21 Years to 60 Years · Male only
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- New York, New York • Purchase, New York